The largest database of trusted experimental protocols

Anti cd105 fitc

Manufactured by Santa Cruz Biotechnology
Sourced in Italy, United States

Anti-CD105 FITC is a fluorescent-labeled antibody that binds to the CD105 (endoglin) cell surface antigen. CD105 is a transmembrane glycoprotein that is highly expressed on endothelial cells and is involved in angiogenesis. The FITC (fluorescein isothiocyanate) label allows for the detection and analysis of CD105-positive cells using flow cytometry or other fluorescence-based techniques.

Automatically generated - may contain errors

2 protocols using anti cd105 fitc

1

Flow Cytometry Profiling of Stem Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
At confluence, the cells derived from the Rigenera digestion method or the lipoaspirates from the digestive solution were detached with trypsin-EDTA (200 mg/L EDTA, 500 mg/L trypsin; Cambrex, Milan, Italy). At least 200,000 cells were, directly placed in incubation using fluorescent conjugated antibodies for 30 min at 4 °C then washed and re-suspended in 0.6 mL. Specimens were examined using FACS Aria II flow cytometry (Becton & Dickinson, Mountain View, CA, USA). The antibodies herein investigated were: anti-CD117 PE (c-kit) (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy); anti-CD34 FITC and PE (Miltenyi-Biotech); anti-CD90 FITC (BD Pharmingen, Buccinasco, Milano, Italy); anti-CD105 FITC (Santa Cruz, CA, USA); anti-CD73 PE (Miltenyi-Biotech); anti-CD29 PE (Miltenyi-Biotech); anti-CD31 FITC (Miltenyi-Biotech); and anti-CD45 Cy and PE (BD Pharmingen).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After digestion, at least 500,000 fresh cells were incubated with primary antibody for 30 min at 4 °C, washed twice in PBS and incubated with a secondary antibody. Antibodies used in this study were as follows: anti-CD117 PE (c-kit) (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-212), anti-CD34 FITC and PE (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-142 and 130-098-140), anti-CD90 FITC (BD Pharmigen, Buccinasco, Milan, Italy—catalog number 555595), anti-CD105 FITC (Santa Cruz, CA, USA—catalog number sc-18838), anti-CD29 Cy (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-101-281), anti-CD31 FITC (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-171), anti-CD133 PE (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-826), anti-CD73 PE (BD Pharmigen, Buccinasco, Milan, Italy—catalog number 550257), anti-CD44 FITC (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-210), anti-CD45 Cy and PE (BD Pharmigen, Buccinasco, Milan, Italy—catalog number 560974 and 555483), and anti-CD14 PE (Miltenyi-Biotech, Calderara di Reno, Bologna, Italy—catalog number 130-098-067). A FACS Vantage (Becton Dickinson) was used. CellQuest software was used for analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!